Tseng Ming-Yuan, Al-Rawi Pippa G, Pickard John D, Rasulo Frank A, Kirkpatrick Peter J
Academic Department of Neurosurgery, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.
Stroke. 2003 Jun;34(6):1389-96. doi: 10.1161/01.STR.0000071526.45277.44. Epub 2003 May 1.
The goal of this study was to examine the effects of hypertonic saline on cerebral blood flow (CBF) in poor-grade patients with subarachnoid hemorrhage.
We administered 23.5% hypertonic saline (2 mL/kg IV) 1 time to 10 patients, 2 times to 7 patients, and 3 times to 1 patient. All patients had transcranial Doppler (TCD), intracranial pressure (ICP) monitoring, and analysis of serum sodium and osmolality; 6 had xenon CT (XeCT). Data were used to characterize the changes in CBF, cerebral vascular resistance (CVR), ICP, cerebral perfusion pressure (CPP), and potential rheological mechanisms of action.
In the first treatment episode, CPP increased 26.8% (P=0.0003, at 28.3 minutes) from a rise in mean arterial blood pressure (ABP) of 10.5% (P=0.02, at 22.2 minutes) and a fall in ICP (-74.7%, P=0.002, at 60.0 minutes). Flow velocity (FV) of the middle cerebral artery increased 70.8% (P=0.00005, at 20.0 minutes), resulting in a corresponding fall in estimated CVR (-26.6%, P=0.01, at 16.3 minutes). The half-lives of effects on ABP, CPP, ICP, FV, and estimated CVR were 20.0, 53.6, 139.1, 42.7, and 27.1 minutes, respectively. In the second treatment episode, all these parameters had the same response except estimated CVR, which did not reach statistical significance. XeCT confirmed the increase in CBF (22.9%, P=0.02) without regional differences. A fall in CBF after hypertonic saline was identified in only a single region of interest in a patient in whom baseline flow was low but not infarcted. Serum sodium rose by 11.4 and 8.8 mmol/L, and osmolality rose by 26.7 and 16.3 mosm/L in the first and second treatment episodes, respectively. Hemoglobin decreased by 0.7 and 0.6 g/L and hematocrit decreased by 1.9% and 2.4% in the first and second treatment episodes, respectively.
We found that 23.5% hypertonic saline increases CBF in poor-grade patients with subarachnoid hemorrhage. These effects are associated with improved indexes of blood rheology. Potential therapeutic benefits are discussed.
本研究旨在探讨高渗盐水对蛛网膜下腔出血病情较差患者脑血流量(CBF)的影响。
我们对10例患者静脉注射1次23.5%高渗盐水(2 mL/kg),7例患者静脉注射2次,1例患者静脉注射3次。所有患者均接受经颅多普勒(TCD)检查、颅内压(ICP)监测以及血清钠和渗透压分析;6例患者接受氙CT(XeCT)检查。数据用于描述CBF、脑血管阻力(CVR)、ICP、脑灌注压(CPP)的变化以及潜在的流变学作用机制。
在首次治疗期间,CPP在28.3分钟时升高了26.8%(P = 0.0003),这是由于平均动脉血压(ABP)在22.2分钟时升高了10.5%(P = 0.02)以及ICP在60.0分钟时下降了-74.7%(P = 0.002)。大脑中动脉血流速度(FV)在20.分钟时增加了70.8%(P = 0.00005),导致估计的CVR相应下降(-26.6%,P = 0.01,在16.3分钟时)。对ABP、CPP、ICP、FV和估计CVR的作用半衰期分别为20.0、53.6、139.1、42.7和27.1分钟。在第二次治疗期间,除估计的CVR外,所有这些参数都有相同的反应,估计的CVR未达到统计学显著性。XeCT证实CBF增加(22.9%,P = 0.02)且无区域差异。仅在1例基线血流较低但未梗死的患者的单个感兴趣区域中发现高渗盐水后CBF下降。在首次和第二次治疗期间,血清钠分别升高11.4和8.8 mmol/L,渗透压分别升高26.7和16.3 mosm/L。血红蛋白在首次和第二次治疗期间分别下降0.7和0.6 g/L,血细胞比容分别下降1.9%和2.4%。\n结论:我们发现23.5%高渗盐水可增加蛛网膜下腔出血病情较差患者的CBF。这些作用与血液流变学指标的改善有关。讨论了潜在的治疗益处。